Analysis of p16(INK4a) and its interaction with CDK4

被引:29
|
作者
Yang, R [1 ]
Serrano, M [1 ]
Slater, J [1 ]
Leung, E [1 ]
Koeffler, HP [1 ]
机构
[1] COLD SPRING HARBOR LAB,COLD SPRING HARBOR,NY 11724
关键词
D O I
10.1006/bbrc.1996.0045
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The interaction between cyclin-dependent kinase 4 (CDK4) and its inhibitor p16(INK4a) (p16) was studied by random mutagenesis and yeast two-hybrid system. The gene encoding p16 was mutagenized randomly and the amino acid changes that affect the binding of p16 to CDK4 were identified. Several amino acid residues were shown to be important for the binding and many of these changes occur at residues conserved in all known human p16 family proteins Most of the mutant p16 proteins that failed to bind to CDK4 contained multiple amino acid changes, and these alterations were observed throughout the entire gene with no apparent mutational patterns or hot spots. Some of the mutations that moderately reduced the binding activity severely affected the kinase-inhibitory activity of p16. (C) 1996 Academic Press, Inc.
引用
收藏
页码:254 / 259
页数:6
相关论文
共 50 条
  • [31] Phosphorylation of p16INK4A correlates with Cdk4 association
    Gump, J
    Stokoe, D
    McCormick, F
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (09) : 6619 - 6622
  • [32] Methylation of the p16(INK4A) gene in multiple myeloma.
    Tasaka, T
    Asou, H
    Munker, R
    Said, J
    Berenson, J
    Koeffler, HP
    BLOOD, 1997, 90 (10) : 1071 - 1071
  • [33] Hypoxia stimulates p16 expression and association with cdk4
    Zygmunt, A
    Tedesco, VC
    Udho, E
    Krucher, NA
    EXPERIMENTAL CELL RESEARCH, 2002, 278 (01) : 53 - 60
  • [34] Infrequent alterations of the p16(INK4A) gene in liver cancer
    Kita, R
    Nishida, N
    Fukuda, Y
    Azechi, H
    Matsuoka, Y
    Komeda, T
    Sando, T
    Nakao, K
    Ishizaki, K
    INTERNATIONAL JOURNAL OF CANCER, 1996, 67 (02) : 176 - 180
  • [35] Role of p16/INK4a in gastrointestinal stromal tumor progression
    Ricci, R
    Arena, V
    Castri, F
    Martini, M
    Maggiano, N
    Murazio, M
    Pacelli, F
    Potenza, AE
    Vecchio, FM
    Larocca, LM
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2004, 122 (01) : 35 - 43
  • [36] Efficacy of CDK4 inhibition against sarcomas depends on their levels of CDK4 and p16ink4 mRNA
    Perez, Marco
    Munoz-Galvan, Sandra
    Jimenez-Garcia, Manuel P.
    Marin, Juan J.
    Carnero, Amancio
    ONCOTARGET, 2015, 6 (38) : 40557 - 40574
  • [37] Frequent inactivation of p16(INK4a) in oral premalignant lesions
    Papadimitrakopoulou, V
    Izzo, J
    Lippman, SM
    Lee, JS
    Fan, YH
    Clayman, G
    Ro, JY
    Hittelman, WN
    Lotan, R
    Hong, WK
    Mao, L
    ONCOGENE, 1997, 14 (15) : 1799 - 1803
  • [38] PROTEIN P16(INK4a) IMMUNOHISTOCHEMICAL EXPRESSION IN ADENOCARCINOMA OF THE ESOPHAGUS
    Osanai, Mario Henrique
    Albano Edelweiss, Maria Isabel
    Meurer, Luise
    Vilwock, Maite de Mello
    Cavazzola, Leandro Totti
    Ribeiro, Guilherme
    Schirmer, Carlos Cauduro
    Gurski, Richard Ricachenevsky
    ABCD-ARQUIVOS BRASILEIROS DE CIRURGIA DIGESTIVA-BRAZILIAN ARCHIVES OF DIGESTIVE SURGERY, 2011, 24 (04): : 277 - 281
  • [39] Alterations of the p16(INK4A) gene in human ovarian cancers
    Kanuma, T
    Nishida, J
    Gima, T
    Barrett, JC
    Wake, N
    MOLECULAR CARCINOGENESIS, 1997, 18 (03) : 134 - 141
  • [40] IDENTIFICATION OF HUMAN AND MOUSE P19, A NOVEL CDK4 AND CDK6 INHIBITOR WITH HOMOLOGY TO P16(INK4)
    CHAN, FKM
    ZHANG, JK
    CHENG, L
    SHAPIRO, DN
    WINOTO, A
    MOLECULAR AND CELLULAR BIOLOGY, 1995, 15 (05) : 2682 - 2688